Tapentadol | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tapentadol
Canada

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Tapentadol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 5 USDMF, 3 CEP/COS, 6 EU WC, 2 KDMF, 5 NDC API, 23 Listed Suppliers, $ API Reference Price

29 API Suppliers
5 USDMF
3 CEP/COS
6 EU WC
2 KDMF
5 NDC API
23 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

216 FDF Dossiers, 30 FDA Orange Book, 115 Europe, 8 Canada, 5 Australia, 5 South Africa, 53 Listed Dossiers

216 FDF Dossiers
30 FDA Orange Book
115 Europe
8 Canada
5 Australia
5 South Africa
53 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 250MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE, SOLUTION;ORAL - EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - EQ 75MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 250MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE
SOLUTION;ORAL - EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 50MG BASE
TABLET;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 2 Seqens, 3 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 19 BASF, 1 Bioplus Life Sciences, 10 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

53 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 31 Controlled & Modified Release, 25 Direct Compression, 18 Granulation, 18 Disintegrants & Superdisintegrants, 17 Thickeners and Stabilizers, 14 Solubilizers, 12 Lubricants & Glidants, 12 Co-Processed Excipients, 11 Topical, 10 Film Formers & Plasticizers, 7 Parenteral, 6 Taste Masking, 5 Empty Capsules, 5 Coloring Agents, 4 API Stability Enhancers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids

53 Fillers, Diluents & Binders
51 Coating Systems & Additives
31 Controlled & Modified Release
25 Direct Compression
18 Granulation
18 Disintegrants & Superdisintegrants
17 Thickeners and Stabilizers
14 Solubilizers
12 Lubricants & Glidants
12 Co-Processed Excipients
11 Topical
10 Film Formers & Plasticizers
7 Parenteral
6 Taste Masking
5 Empty Capsules
5 Coloring Agents
4 API Stability Enhancers
4 Vegetarian Capsules
3 Emulsifying Agents
3 Rheology Modifiers
3 Chewable & Orodispersible Aids

DIGITAL CONTENT

30 NEWS #PharmaBuzz

30 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 93 Finished Drug Prices

2 US Medicaid Prescriptions
93 Finished Drug Prices

MARKET PLACE

26 APIs, 2 FDF Dossiers

26 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

53 US Patents, 8 US Exclusivities, 56 Health Canada Patents

53 US Patents
8 US Exclusivities
56 Health Canada Patents

$ API Ref.Price (USD/KG) : 520 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8ENDO OPERATIONS LTD.

filter Active Ingredients Reset all filters

8 All

01 8TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

filter Dosage Form Reset all filters

8 All

01 5TABLET (EXTENDED-RELEASE)

02 3TABLET (IMMEDIATE RELEASE)

filter Brand Name Reset all filters

8 All

01 5NUCYNTA EXTENDED-RELEASE

02 3NUCYNTA IR

List of Suppliers

Product Main Page

01

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

Brand Name : NUCYNTA EXTENDED-RELEASE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 50MG

Packaging : 60

Approval Date :

Application Number : 2415577

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

Brand Name : NUCYNTA EXTENDED-RELEASE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 100MG

Packaging : 60

Approval Date :

Application Number : 2415585

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

Brand Name : NUCYNTA EXTENDED-RELEASE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 150MG

Packaging : 60

Approval Date :

Application Number : 2415593

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

Brand Name : NUCYNTA EXTENDED-RELEASE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 200MG

Packaging : 60

Approval Date :

Application Number : 2415607

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

Brand Name : NUCYNTA EXTENDED-RELEASE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 250MG

Packaging : 60

Approval Date :

Application Number : 2415615

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

Brand Name : NUCYNTA IR

Dosage Form : TABLET (IMMEDIATE RELEASE)

Dosage Strength : 50MG

Packaging : 100

Approval Date :

Application Number : 2378272

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

Brand Name : NUCYNTA IR

Dosage Form : TABLET (IMMEDIATE RELEASE)

Dosage Strength : 75MG

Packaging : 100

Approval Date :

Application Number : 2378280

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

ENDO OPERATIONS LTD.

Country

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

TAPENTADOL (TAPENTADOL HYDROCHLORIDE)

Brand Name : NUCYNTA IR

Dosage Form : TABLET (IMMEDIATE RELEASE)

Dosage Strength : 100MG

Packaging : 100

Approval Date :

Application Number : 2378299

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?